National Sciences

National Resilience, commonly known as Resilience, is a technology-focused biomanufacturing company dedicated to democratizing access to complex medicines. The company provides a comprehensive network of high-tech manufacturing solutions across multiple modalities, including biologics, vaccines, nucleic acids, and cell and gene therapies. By integrating advanced software, automation, and novel manufacturing technologies, Resilience aims to build a more robust and sustainable supply chain for the global biopharmaceutical industry. Their services span from early-stage process development through to commercial-scale production and fill-finish operations.